Article
Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities
22 Jul 2021
Abstract excerpt
(Mtb) infection, affecting nearly one-third of the world's population. However, because the pathogenesis of TB is still not fully understood and the development of anti-TB drug is slow, TB remains a global public health problem. In recent years, with the gradual discovery and confirmation of the immunomodulatory properties of mesenchymal stem cells (MSCs), more and more studies, including our team's research,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
